We are live on ! Find out more
RCUS icon

Arcus Biosciences
RCUS

92 hedge funds and large institutions have $375M invested in Arcus Biosciences in 2020 Q1 according to their latest regulatory filings, with 26 funds opening new positions, 26 increasing their positions, 26 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

225% more first-time investments, than exits

New positions opened: 26 | Existing positions closed: 8

37% more capital invested

Capital invested by funds: $274M → $375M (+$101M)

23% more funds holding

Funds holding: 75 → 92 (+17)

0% more funds holding in top 10

Funds holding in top 10: 4 → 4 (0)

0% more repeat investments, than reductions

Existing positions increased: 26 | Existing positions reduced: 26

0.37% less ownership

Funds ownership: 59.1% → 58.73% (-0.37%)

100% less call options, than puts

Call options by funds: $0 | Put options by funds: $8K

Holders
92
Holders Change
+17
Holders Change %
+22.67%
% of All Funds
2.03%
Holding in Top 10
4
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.09%
New
26
Increased
26
Reduced
26
Closed
8
Calls
–
Puts
$8K
Net Calls
-$8K
Net Calls Change
-$21K

Top Buyers

Rank Fund Capital Flow
1
BC
Boxer Capital
California
+$17.6M
2
PHS
PFM Health Sciences
California
+$10.1M
3
Franklin Resources
Franklin Resources
California
+$5.66M
4
Millennium Management
Millennium Management
New York
+$3.77M
5
Invesco
Invesco
Georgia
+$3.56M

Top Sellers

Rank Fund Capital Flow
1
BI
BVF Inc
California
-$44M
2
EC
EcoR1 Capital
California
-$5.44M
3
Janus Henderson Group
Janus Henderson Group
United Kingdom
-$2.99M
4
BlackRock
BlackRock
New York
-$2.84M
5
JP Morgan Chase
JP Morgan Chase
New York
-$999K
Name Holding Trade Value Shares
Change 		Change in
Stake
BBA
26
Baker Bros. Advisors
New York
$1.69M – – –
Alkeon Capital Management
27
Alkeon Capital Management
New York
$1.67M +$1.49M +120,000 New
PIM
28
Platinum Investment Management
Australia
$1.44M – – –
Allianz Asset Management
29
Allianz Asset Management
Germany
$1.4M +$1.25M +100,722 New
WP
30
Woodline Partners
California
$1.37M +$1.23M +98,516 New
Federated Hermes
31
Federated Hermes
Pennsylvania
$1.35M +$1.14M +91,309 +1,497%
PA
32
Parallel Advisors
California
$1.22M +$9.44K +759 +0.9%
Goldman Sachs
33
Goldman Sachs
New York
$1.16M -$486K -39,079 -32%
Fidelity Investments
34
Fidelity Investments
Massachusetts
$1.1M +$990K +79,630 New
Two Sigma Advisers
35
Two Sigma Advisers
New York
$1.03M +$11.2K +900 +1%
California Public Employees Retirement System
36
California Public Employees Retirement System
California
$914K +$44.8K +3,600 +6%
RhumbLine Advisers
37
RhumbLine Advisers
Massachusetts
$754K +$64K +5,145 +10%
Two Sigma Investments
38
Two Sigma Investments
New York
$753K -$879K -70,702 -57%
State of Wisconsin Investment Board
39
State of Wisconsin Investment Board
Wisconsin
$695K +$34.8K +2,800 +6%
California State Teachers Retirement System (CalSTRS)
40
California State Teachers Retirement System (CalSTRS)
California
$685K -$15.8K -1,271 -3%
Swiss National Bank
41
Swiss National Bank
Switzerland
$618K +$16.2K +1,300 +3%
PAM
42
Panagora Asset Management
Massachusetts
$613K +$528K +42,475 +2,482%
Bank Julius Baer & Co
43
Bank Julius Baer & Co
Switzerland
$538K +$482K +38,749 New
AllianceBernstein
44
AllianceBernstein
Tennessee
$537K +$101K +8,100 +26%
BI
45
BVF Inc
California
$535K -$44M -3,540,449 -99%
MML Investors Services
46
MML Investors Services
Massachusetts
$500K -$65K -5,225 -13%
GCP
47
GSA Capital Partners
United Kingdom
$462K -$464K -37,300 -53%
Citadel Advisors
48
Citadel Advisors
Florida
$439K -$317K -25,494 -45%
New York State Common Retirement Fund
49
New York State Common Retirement Fund
New York
$407K – – –
DCM
50
DAFNA Capital Management
California
$386K +$346K +27,798 New
1
2
3 4

RCUS Hedge Fund Activity: Q1 2020 in Review

92 of the 4,538 institutional investors tracked by Wall St. Rank reported a position in Arcus Biosciences (RCUS) for Q1 2020, worth a combined $375M — up 37% from $274M a quarter earlier.

Buyers outnumbered sellers: 26 funds opened new RCUS positions and 8 closed out — a net gain of 18 holders — while 26 added to existing stakes and 26 trimmed.

The largest buyer was Boxer Capital, adding an estimated $17.6M. The largest seller was BVF Inc, cutting an estimated $44M.

  • 92 institutional investors held Arcus Biosciences (RCUS) as of Q1 2020, up from 75 in Q4 2019.
  • Funds reported $375M of Arcus Biosciences stock for Q1 2020, up 37% quarter-over-quarter.
  • 26 funds opened new Arcus Biosciences positions in Q1 2020 and 8 closed out, a net change of +18 holders.
  • The largest Arcus Biosciences buyer in Q1 2020 was Boxer Capital, an estimated $17.6M added.
  • The largest Arcus Biosciences seller in Q1 2020 was BVF Inc, an estimated $44M sold.

Based on aggregated 13F filings for Q1 2020.